Clinical characteristics, prognostic factors, and feasibility of ICI continuation in immune checkpoint inhibitor-related pneumonitis

The similar characteristics of ICI-pneumonitis across malignancies support the generalizability of management strategies. Approximately one-fifth of patients successfully continued ICI therapy after pneumonitis. Systematic radiological surveillance and appropriate severity-based treatment may help optimize outcomes in patients receiving ICI therapy.